The last IMIBIC-P2Med fellow joined the programme in May 2022. Silvia has enjoyed before an MSCA-Individual Fellowship in the same group since her return to IMIBIC in 2019. Most of the fellows are finishing their second year (Maribel, Marina, Almudena…
Vaccination is widely considered one of the greatest achievements of modern medicine. Vaccines save millions of lives and protect millions more from getting sick. However, each year roughly three million individuals still die of vaccine-preventable diseases, including respiratory infections, tuberculosis,…
A recently published Open Access article represents the first demonstration that the plasma levels of miR-107 might represent a useful personalized diagnostic biomarker of prostate cancer since its levels are increased in plasma from prostate cancer patients compared with control…
Alexander Batista-Duharte has been invited as a guest editor of a special issue of Vaccines (ISSN 2076-393X), an Open Access journal of MDPI. The deadline for manuscript submissions is 31 March 2023. Dear Colleagues, Vaccine development has evolved from…
MultiQC is an open-source tool developed by Phil Ewels, Lead for Bioinformatics developer at National Genomics Infrastructure, part of the Science for Life Laboratory in Stockholm. It aggregates results from bioinformatics analyses across many samples into a single report. Sounds…
Marina Mora and Almudena Pino both apply bioinformatics and other computational methods in their research. In 2021 they teamed up with the IMIBIC Bioinformatics Unit to organise a beginners’ course in R for basic biostatistics. Skills in this area were…
